title: [Nephrogenous diabetes insipidus secondary to the administration of amphotericin B and liposomal amphotericin B].
authors.forename: J J
authors.initials: JJ
authors.lastname: Araujo
authors.forename: A
authors.initials: A
authors.lastname: Domínguez
authors.forename: C
authors.initials: C
authors.lastname: Bueno
authors.forename: J
authors.initials: J
authors.lastname: Rodríguez
authors.forename: M J
authors.initials: MJ
authors.lastname: Ríos
authors.forename: M A
authors.initials: MA
authors.lastname: Muniain
authors.forename: R
authors.initials: R
authors.lastname: Pérez
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D003919:Diabetes Insipidus / Q000139:chemically induced*; D003928:Diabetic Nephropathies / Q000139:chemically induced*; D006801:Humans; D008081:Liposomes; D008297:Male
chemical_list: D000935:Antifungal Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B
vernacular_title: Diabetes insípida nefrogénica secundaria a la administración de anfotericina B y anfotericina B liposomal.